Immunitybio, Inc. (IBRX) SEC Filings — 2024
14 SEC filings for Immunitybio, Inc. (IBRX) in 2024.
Filings
- ImmunityBio Enters Material Definitive Agreement — 8-K · Dec 11, 2024
- ImmunityBio Files 8-K: Financial Statements and Exhibits — 8-K · Dec 10, 2024
- ImmunityBio Files 8-K: Other Events & Financials — 8-K · Nov 19, 2024
- ImmunityBio Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- ImmunityBio Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- ImmunityBio Files 8-K for Material Definitive Agreement — 8-K · Jul 18, 2024
- ImmunityBio Files 8-K for Shareholder Votes and Financials — 8-K · Jun 12, 2024
- ImmunityBio, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- ImmunityBio, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- ImmunityBio to Acquire Atara Biotherapeutics for $1B — 8-K · Apr 23, 2024
- ImmunityBio, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- ImmunityBio Amends Officer Compensation, Code of Ethics — 8-K · Feb 26, 2024
- Soon-Shiong Group Lowers ImmunityBio Stake to 32.7% — SC 13D/A · Jan 4, 2024
- ImmunityBio Reports New Debt, Equity Sales, Material Agreement — 8-K · Jan 2, 2024